KindlyMD, a healthcare and healthcare data company integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the closing of its previously announced initial public offering of 1,240,910 units at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the company.
Each Unit is comprised of one share of the company's common stock with $0.001 par value per share, one tradable warrant to purchase one share of Common Stock at an exercise price of $6.33 per share, and one non-tradable warrant to purchase one-half of one share of Common Stock at an exercise price of $6.33 per share.
The shares and Tradeable Warrants began trading on the Nasdaq Capital Market on May 31, 2024, under the symbols "KDLY" and "KDLYW," respectively.
In addition, KindlyMD has granted the underwriters a 45-day option to purchase, at the public offering price, up to an additional 186,136 shares of Common Stock and/or 186,136 Tradable Warrants, and/or 186,136 Non-Tradable Warrants, or any combination thereof, at the public offering price per share of Common Stock and per Warrant, respectively, less, in each case, underwriting discounts and commissions, on the same terms as set forth in this prospectus, solely to cover over-allotments, if any.
